12:00 AM
Oct 11, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Genous Bio-engineered R stent: Phase II/III data

The single-blind, German Phase II/III PERfECT STENT trial in 120 patients undergoing percutaneous coronary intervention (PCI) showed that the Genous Bio-engineered R stent in combination with a paclitaxel-coated balloon met the primary endpoint of significantly lower in-stent late loss at 6 months...

Read the full 186 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >